Trademark: 87904444
Word
PLIMGOA
Status
Registered
Status Code
700
Status Date
Tuesday, December 25, 2018
Serial Number
87904444
Registration Number
5637303
Registration Date
Tuesday, December 25, 2018
Mark Type
4000
Filing Date
Wednesday, May 2, 2018
Published for Opposition
Tuesday, October 9, 2018

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Dec 25, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 25, 2018
Registered-Principal Register
Oct 9, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 9, 2018
Published For Opposition
Sep 19, 2018
Notification Of Notice Of Publication E-Mailed
Sep 5, 2018
Electronic Record Review Complete
Aug 24, 2018
On Hold - Electronic Record Review Required
Aug 23, 2018
Approved For Pub - Principal Register
Aug 23, 2018
Assigned To Examiner
May 11, 2018
New Application Office Supplied Data Entered
May 5, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24